Free Cash Flow Build Up
Relmada Therapeutics, Inc. (RLMD)
$2.94
+0.10 (+3.52%)
Year A/P |
Revenue |
---|
EBITDA |
EBIT |
Tax Rate |
EBIAT |
Depreciation |
Accounts Receivable |
Inventories |
Accounts Payable |
Capital Expenditure |
UFCF |
WACC |
PV UFCF |
SUM PV UFCF |